-
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
来源: Buzz FX / 09 10月 2024 02:56:09 America/New_York
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat October 9, 2024 Share Link copied to clipboard. Day One Biopharmaceuticals, Inc.
Read more...